TEI Biosciences Inc. Sustainability Profile
TEI Biosciences Inc., a leading innovator in the biotechnology sector, is headquartered in the United States, with significant operations across various regions. Founded in 2005, the company has established itself as a pioneer in regenerative medicine, focusing on advanced tissue engineering and biomaterials. TEI Biosciences is renowned for its unique core products, including innovative solutions for soft tissue repair and regeneration, which leverage cutting-edge technology to enhance patient outcomes. The company’s commitment to quality and efficacy has positioned it as a trusted partner in the healthcare industry, achieving notable milestones in product development and clinical applications. With a strong market presence, TEI Biosciences continues to drive advancements in the field, contributing to the evolution of surgical practices and improving the quality of life for patients worldwide.
DitchCarbon Score
How does TEI Biosciences Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
TEI Biosciences Inc.'s score of 44 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
TEI Biosciences Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Integra LifeSciences Holdings Corporation, which may influence its climate commitments and emissions reporting. As of now, TEI Biosciences Inc. has not established any documented reduction targets or specific climate pledges. The absence of emissions data suggests that the company may still be in the early stages of developing its sustainability strategy or reporting framework. Given its affiliation with Integra LifeSciences, any climate initiatives or emissions data may be inherited from this parent company. However, specific details regarding emissions performance or reduction targets from Integra LifeSciences Holdings Corporation have not been disclosed in the available information. In summary, while TEI Biosciences Inc. is part of a larger corporate family that may have climate commitments, it currently lacks specific emissions data and reduction initiatives of its own.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 13,902,000 | 00,000,000 | 0,000,000 |
| Scope 2 | 18,609,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | 000,000,000 | 000,000,000 |
How Carbon Intensive is TEI Biosciences Inc.'s Industry?
How Carbon Intensive is TEI Biosciences Inc.'s Location?
TEI Biosciences Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
TEI Biosciences Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
